EXHIBIT 23.1
| Tel: 858-404-9200 | 3570 Carmel Mountain Road |
Consent of Independent Registered Public Accounting Firm
Seelos Therapeutic, Inc.
New York, New York
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of Seelos Therapeutics, Inc. of our report dated March 28, 2019 relating to the consolidated financial statements of Seelos Therapeutics, Inc. (formerly Apricus Biosciences, Inc.) or the "Company," which is contained in that Registration Statement. Our report contains an explanatory paragraph regarding the Company's ability to continue as a going concern.
We also consent to the reference to us under the caption "Experts" in the Registration Statement.
/s/ BDO USA, LLP
San Diego, California
January 21, 2020